Guardant Health (GH) Stock: Buy, Sell, or Hold?
GH - Guardant Health, Inc. Common Stock
$182.59
4.53 (2.54%)
▲
5d:
+9.56%
30d:
+2.73%
90d:
+19.85%
WAIT
LOW Confidence
Analysis Updated: Oct 28, 2026 12:00 AM ET
Earnings: Nov 05, 2026
7d
Get Alerted When GH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: GH shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: GH shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: GH is currently trading at $182.59, which is considered extended relative to its 30-day fair value range of $163.64 to $178.69.
Technical Outlook: Technically, GH is in a strong uptrend. The price is approaching resistance at $186.03. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: GH scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $201.64 (+13.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GH is in a strong uptrend. The price is approaching resistance at $186.03. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: GH scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $201.64 (+13.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$163.64 -
$178.69
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
23.7%
Protect Your Profits
Holding GH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($201.64)
- WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$163.64 -
$178.69
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$155.00
Resistance Level
$186.03
Current Trend
Strong Uptrend
Technical data as of
Oct 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-469.57
Wall Street Target
$201.64
(+13.2%)
Revenue Growth (YoY)
44.3%
Profit Margin
-38.3%
Share & Embed Analysis
Last updated: October 28, 2026 4:29 PM ET
Data refreshes hourly during market hours. Next update: 5:29 PM
Data refreshes hourly during market hours. Next update: 5:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$751 | 52 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$411 | 45 HOLD |
|
IQV
IQVIA Holdings Inc |
STRONG BUY
21 analysts |
$303 | 44 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$259 | 33 SELL |
Advanced GH Option Strategies
Professional options setups generated by AI based on today's GH price and gamma walls.
